Associate Professor
Department of Emergency Medicine |

|
|
|
Sabine Brouxhon, M.D., a clinician scientist,
joined our Department of Emergency Medicine on January 1, 2009 as Associate
Professor. Dr. Brouxhon serves as an attending of the Emergency Department
in Stony Brook University Hospital, as well as pursues fully funded basic
science/translational research programs in her laboratory.
Dr. Brouxhon obtained her M.D. with
Distinctions in Research as well as completed Emergency Medicine
Residency at the University of Rochester. She started her academic
career at her alma mater in 2002 as an Assistant Professor of Emergency
Medicine and physician attending at Strong Memorial and Highland Hospital
Emergency Departments. Dr. Brouxhon also moonlighted at a rural hospital
(Soldiers & Sailors) while in her last year of residency training.
In addition to clinical endeavors, Dr. Brouxhon received over 5 years of
post doctoral research training at the University of Rochester, where she
held joint appointments in the Departments of Surgery and Dermatology.
Her research interests are in cancer research
and wound healing. As a clinician-scientist, Dr Brouxhon is an advocate
of interdisciplinary collaborations that integrate clinical practice with
basic science research, so that her research can progress from the bench-
to - bedside - to - curb. Dr. Brouxhon has enjoyed continuous research
funding for more than 10 years through the Emergency Medicine Foundation, Society
of Academic Emergency Medicine, Wilmot Foundation, the National Institutes
of Health and the Komen Foundation. Currently, Dr. Brouxhon is a recipient
of 2 NIH grants, one from the National Cancer Institute and another from
the National Institute of Environmental Health Sciences, as well as a grant
from the Susan G. Komen Cancer Foundation. Recently, Stony
Brook University, in support of Dr. Brouxhon’s cutting edge research,
is in the process of filing an application with the United States Patent
Office for her invention on the use of a new chemotherapeutic agent for
epithelial cancers.
|